KING PHARMACEUTICALS (KG) Total Debt (2024 - 2026)
KING PHARMACEUTICALS (KG) total debt from Jun 30, 2024 to Mar 31, 2026. The current KING PHARMACEUTICALS (KG) total debt is $843M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Debt
Total Debt
KING PHARMACEUTICALS (KG) Total Debt CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +301136.67% |
Annual Total Debt change of KING PHARMACEUTICALS (KG)
| Year | Total Debt | Change |
|---|---|---|
| 2024 | $900K | N/A |
Comparison KING PHARMACEUTICALS (KG) total debt with competitors
KING PHARMACEUTICALS (KG) total debt is $842.79M.
| Ticker | Name | Total Debt | Upside |
|---|---|---|---|
| OXBR | Oxbridge Re Holdings Ltd | $2.12M | -99.75% |
| GLRE | Greenlight Capital Re Ltd - Class A | $1.53B | +81.31% |
| HG | Hamilton Insurance Group Ltd - Class B | $7.11B | +743.75% |
| SPNT | SiriusPoint Ltd | $10.18B | +1107.85% |
| RNR | RenaissanceRe Holdings Ltd | $35.16B | +4071.97% |
| EG | Everest Group Ltd | $47.05B | +5482.77% |
| RGA | Reinsurance Group Of America Inc | $150.68B | +17778.71% |